Single-cell transcriptomic insights into the immune heterogeneity of immune checkpoint inhibitors related organ toxicities
Immune checkpoint inhibitors (ICIs) have revolutionized cancer therapy, but their increasing clinical use has led to an increasing incidence of immune-related adverse events (irAEs), among which colitis and cardiotoxicity are particularly severe, compromising both quality of lif…